台股 » 個股 » 厚生 » 籌碼相關 » 券商分點績效

厚生

(2107)
可現股當沖
  • 股價
    26.95
  • 漲跌
    ▼0.45
  • 漲幅
    -1.64%
  • 成交量
    1,188
  • 產業
    上市 橡膠類股
  • 202人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
厚生 (2107)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/23     後一日»

券商獲利排行 - 2024/04/23

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  5.55%141.60.2141.497100325.525.525.627
  5.78%10601067272025.525.5027
  5.38%68.60.6684750325.525.525.727
  5.38%53.7053.73939025.625.6027
  4.77%51.11.249.83342925.525.425.627
  5.48%280282020025.625.6027
  5.13%23.70.323.41718125.625.625.927
  4.83%23.40.922.51519425.525.425.727
  4.23%21.9021.91920125.825.825.827
  3.67%18.83.415.310201025.525.425.827
  5.86%17.9017.91212025.525.5027
  4.47%170.216.91015425.425.425.527
  5.54%15.6015.61111025.525.5027
  5.89%150151010025.525.5027
  4.96%12.7-0.212.8910125.525.525.427
  5.24%9.409.477025.625.6027
  6.10%9.309.366025.425.4027
  4.34%90988025.825.8027
  4.33%8.90.18.878125.725.725.827
  5.69%8.708.766025.525.5027
  6.52%8.308.355025.325.3027
  6.19%7.907.955025.425.4027
  5.36%6.906.955025.625.6027
  5.07%6.506.555025.725.7027
  6.10%6.206.244025.425.4027
  3.93%61.14.936325.525.325.727
  5.89%60634025.525.525.627
  5.79%5.905.944025.525.5027
  5.48%5.605.644025.625.6027
  5.07%5.205.244025.725.7027
  1.12%4.90.64.23171425.625.525.627
  6.29%4.804.833025.425.4027
  5.89%4.504.533025.525.5027
  5.55%4.304.333025.525.5027
  3.57%3.70.6324225.525.425.827
  1.37%3.5-0.74.2310725.525.625.527
  4.26%3.303.333025.925.9027
  6.52%3.303.322025.325.3027
  6.52%3.303.322025.325.3027
  6.31%3.203.222025.425.4027
  6.10%3.103.122025.425.4027
  6.10%3.103.122025.425.4027
  1.01%3.13.100121225.725.525.827
  6.00%3.103.122025.425.4027
  2.98%30.22.924225.525.525.627
  5.89%30322025.525.5027
  5.89%30322025.525.5027
  5.79%30322025.525.5027
  5.69%2.902.922025.525.5027
  5.69%2.902.922025.525.5027

券商虧損排行 - 2024/04/23

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -5.40%-181.9-2.4-179.5-123913225.525.825.527
  -6.08%-66.50-66.5-4304325.4025.427
  -4.97%-47.20-47.2-3703725.7025.727
  -1.61%-43.2-16.6-26.5-188710525.625.725.527
  -6.52%-330-33-2002025.3025.327
  -5.16%-31.80-31.8-2402425.6025.627
  -5.54%-29.70-29.7-2102125.5025.527
  -6.33%-20.90-20.9-1301325.3025.327
  -4.71%-20.60-20.6-1701725.7025.727
  -5.74%-16.10-16.1-1101125.5025.527
  -5.77%-14.70-14.7-1001025.5025.527
  -5.71%-14.60-14.6-901025.525.425.527
  -5.69%-14.50-14.5-1001025.5025.527
  -5.66%-130-13-90925.5025.527
  -6.31%-12.80-12.8-80825.4025.427
  -6.08%-12.40-12.4-80825.4025.427
  -4.66%-120-12-1001025.8025.827
  -5.89%-120-12-80825.5025.527
  -5.27%-10.80-10.8-80825.6025.627
  -4.24%-9.80.1-9.8-72925.525.525.527
  -2.50%-9.60.9-10.5-871525.625.525.627
  -6.31%-9.60-9.6-60625.4025.427
  -5.89%-90-9-60625.5025.527
  -5.89%-90-9-60625.5025.527
  -5.65%-8.70-8.7-60625.5025.527
  -6.52%-8.30-8.3-50525.3025.327
  -6.31%-80-8-50525.4025.427
  -6.31%-80-8-50525.4025.427
  -5.64%-7.20-7.2-50525.5025.527
  -5.60%-7.20-7.2-50525.5025.527
  -6.36%-6.50-6.5-40425.3025.327
  -6.31%-6.40-6.4-40425.4025.427
  -4.66%-60-6-50525.8025.827
  -5.55%-5.70-5.7-40425.525.325.527
  -5.48%-5.60-5.6-30425.525.425.627
  -5.38%-5.50-5.5-40425.6025.627
  -6.45%-4.90-4.9-30325.3025.327
  -5.89%-4.50-4.5-30325.5025.527
  -5.48%-4.20-4.2-30325.6025.627
  -5.27%-4.10-4.1-30325.6025.627
  -4.46%-3.50-3.5-30325.8025.827
  -4.26%-3.30-3.3-30325.9025.927
  -6.52%-3.30-3.3-20225.3025.327
  -6.31%-3.20-3.2-20225.4025.427
  -6.31%-3.20-3.2-20225.4025.427
  -6.31%-3.20-3.2-10225.425.825.427
  -6.31%-3.20-3.2-20225.4025.427
  -6.10%-3.10-3.1-20225.4025.427
  -6.10%-3.10-3.1-20225.4025.427
  -6.10%-3.10-3.1-10225.425.425.427
昱厚生技盼加速鼻噴劑型應用 推進三產品臨床試驗Anue鉅亨-2023/06/30
昱厚生技鼻噴氣喘新藥 將啟動學術二期臨床試驗Anue鉅亨-2023/04/17
高雄國賓吹熄燈號 欣陸攜手厚生投入危老合建案 擬2024年推案Anue鉅亨-2021/11/15
厚生 相關文章
厚生 相關影音